Allergan Plc (AGN) Files Form 4 Insider Selling : Nesli Basgoz Sells 459 Shares

Allergan Plc (AGN): Nesli Basgoz , director of Allergan Plc sold 459 shares on May 11, 2016. The Insider selling transaction was reported by the company on May 12, 2016 to the Securities and Exchange Commission. The shares were sold at $225.10 per share for a total value of $103,320.90 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Dec 9, 2015, Nesli Basgoz (director) sold 2,300 shares at $312.96 per share price.On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price.Also, On Aug 24, 2015, Paul Bisaro (Exec Chairman) purchased 1,000 shares at $297.42 per share price.

Allergan plc Ordinary Shares: On Tuesday, May 10, 2016 heightened volatility was witnessed in Allergan plc Ordinary Shares which led to swings in the share price. The shares opened for trading at $223.5 and hit $228.72 on the upside , eventually ending the session at $225, with a gain of 5.28% or 11.29 points. The heightened volatility saw the trading volume jump to 1,06,16,704 shares. The 52-week high of the share price is $340.34 and the company has a market cap of $88,805 M . The 52-week low of the share price is at $195.5.

Allergan plc Ordinary Shares Money Flow Index Chart

Company has been under the radar of several Street Analysts.Allergan plc Ordinary Shares is Downgraded by Piper Jaffray to Neutral while Lowering the Price Target of the company shares to $ 238 from a previous price target of $311 . Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Initiated by Guggenheim to Neutral. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Resumed by Goldman to Buy and the brokerage firm has set the Price Target at $275. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Resumed by Morgan Stanley to Overweight and the brokerage firm has set the Price Target at $300. The Rating was issued on Apr 7, 2016.Allergan plc Ordinary Shares is Reiterated by UBS to Buy while Lowering the Price Target of the company shares to $ 300 from a previous price target of $366 . The Rating was issued on Apr 7, 2016.

Leave a Reply

Allergan plc Ordinary Shares - Is it time to Sell?

Top Brokerage Firms are advising their investors on Allergan plc Ordinary Shares. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.